IRIDEX IRIX Stock
IRIDEX Price Chart
IRIDEX IRIX Financial and Trading Overview
IRIDEX stock price | 0.86 USD |
Previous Close | 1.91 USD |
Open | 1.97 USD |
Bid | 0 USD x 2900 |
Ask | 0 USD x 800 |
Day's Range | 1.96 - 2.02 USD |
52 Week Range | 1.76 - 3.49 USD |
Volume | 17.06K USD |
Avg. Volume | 15.78K USD |
Market Cap | 32.33M USD |
Beta (5Y Monthly) | 1.236267 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.54 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.63 USD |
IRIX Valuation Measures
Enterprise Value | 21.05M USD |
Trailing P/E | N/A |
Forward P/E | -9.181818 |
PEG Ratio (5 yr expected) | -0.19 |
Price/Sales (ttm) | 0.5643913 |
Price/Book (mrq) | 2.0362904 |
Enterprise Value/Revenue | 0.367 |
Enterprise Value/EBITDA | -2.965 |
Trading Information
IRIDEX Stock Price History
Beta (5Y Monthly) | 1.236267 |
52-Week Change | -26.0073% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.49 USD |
52 Week Low | 1.76 USD |
50-Day Moving Average | 2.21 USD |
200-Day Moving Average | 2.25 USD |
IRIX Share Statistics
Avg. Volume (3 month) | 15.78K USD |
Avg. Daily Volume (10-Days) | 19.61K USD |
Shares Outstanding | 16.01M |
Float | 12.16M |
Short Ratio | 3.04 |
% Held by Insiders | 26.62% |
% Held by Institutions | 22.52% |
Shares Short | 46.85K |
Short % of Float | 0.33% |
Short % of Shares Outstanding | 0.28% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | April 1, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -12.64% |
Operating Margin (ttm) | -13.28% |
Gross Margin | 44.21% |
EBITDA Margin | -12.39% |
Management Effectiveness
Return on Assets (ttm) | -10.68% |
Return on Equity (ttm) | -38.94% |
Income Statement
Revenue (ttm) | 57.29M USD |
Revenue Per Share (ttm) | 3.59 USD |
Quarterly Revenue Growth (yoy) | 2.39% |
Gross Profit (ttm) | 25.37M USD |
EBITDA | -7099000 USD |
Net Income Avi to Common (ttm) | -7246000 USD |
Diluted EPS (ttm) | -0.49 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 11.05M USD |
Total Cash Per Share (mrq) | 0.69 USD |
Total Debt (mrq) | 1.52M USD |
Total Debt/Equity (mrq) | 9.56 USD |
Current Ratio (mrq) | 2.636 |
Book Value Per Share (mrq) | 0.992 |
Cash Flow Statement
Operating Cash Flow (ttm) | -9109000 USD |
Levered Free Cash Flow (ttm) | -3806625 USD |
Profile of IRIDEX
Country | United States |
State | CA |
City | Mountain View |
Address | 1212 Terra Bella Avenue |
ZIP | 94043 |
Phone | 650 940 4700 |
Website | https://www.iridex.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 130 |
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
Q&A For IRIDEX Stock
What is a current IRIX stock price?
IRIDEX IRIX stock price today per share is 0.86 USD.
How to purchase IRIDEX stock?
You can buy IRIX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IRIDEX?
The stock symbol or ticker of IRIDEX is IRIX.
Which industry does the IRIDEX company belong to?
The IRIDEX industry is Medical Devices.
How many shares does IRIDEX have in circulation?
The max supply of IRIDEX shares is 16.64M.
What is IRIDEX Price to Earnings Ratio (PE Ratio)?
IRIDEX PE Ratio is now.
What was IRIDEX earnings per share over the trailing 12 months (TTM)?
IRIDEX EPS is -0.54 USD over the trailing 12 months.
Which sector does the IRIDEX company belong to?
The IRIDEX sector is Healthcare.
IRIDEX IRIX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
NASDAQ Global Market Composite NQGM | 1647.83 USD — |
-5.17
|
— — | 1610.28 USD — | 1681.06 USD — | — - | — — |
NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 19079.55 USD — |
-5.82
|
— — | 19064.73 USD — | 19740.96 USD — | — - | — — |
- {{ link.label }} {{link}}